Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick L Wagner

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Current Oncology (Toronto, Ont.)|September 26, 2025
The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal CarcinomatosisChristopher Sherry, Neda Dadgar, Zuqiang Liu, et al.
Journal of Translational Medicine|April 30, 2024
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosisNeda Dadgar, Christopher Sherry, Jenna Zimmerman, et al.
British Journal of Cancer|September 13, 2022
A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinomaAli H Zaidi, Muhammad Yogi Pratama, Ashten N Omstead, et al.
American Journal of Clinical Pathology|September 19, 2009
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinomaPatrick L Wagner, Sven Perner, David S Rickman, et al.
Cancers|November 13, 2025
Blood-Based Surveillance Biomarkers for Gastroesophageal CancersNeda Dadgar, Muhammad Anees, Christopher Sherry, et al.
Handbook of Experimental Pharmacology|October 29, 2025
GPCR Biased Signaling in CancerAriella C Avigad, Melody Zhou, Chengyu Sun, et al.
Diseases of the Colon and Rectum|March 20, 2012
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasisPatrick L Wagner, Douglas Jones, Anna Aronova, et al.
Cancers|February 13, 2025
Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of SurvivalChelsea Knotts, Hyun Park, Christopher Sherry, et al.
Clinical and Translational Medicine|March 23, 2026
Liquid biopsy biomarkers for early detection of gastrointestinal cancers: Current landscape and emerging technologiesMuhammad Anees, Christopher Sherry, Hyun Y Park, et al.
Carcinogenesis|May 13, 2022
CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat modelAshten N Omstead, Michael Paskewicz, Anastasia Gorbunova, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Current Oncology (Toronto, Ont.)|September 26, 2025
The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal CarcinomatosisChristopher Sherry, Neda Dadgar, Zuqiang Liu, et al.
Journal of Translational Medicine|April 30, 2024
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosisNeda Dadgar, Christopher Sherry, Jenna Zimmerman, et al.
British Journal of Cancer|September 13, 2022
A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinomaAli H Zaidi, Muhammad Yogi Pratama, Ashten N Omstead, et al.
American Journal of Clinical Pathology|September 19, 2009
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinomaPatrick L Wagner, Sven Perner, David S Rickman, et al.
Cancers|November 13, 2025
Blood-Based Surveillance Biomarkers for Gastroesophageal CancersNeda Dadgar, Muhammad Anees, Christopher Sherry, et al.
Handbook of Experimental Pharmacology|October 29, 2025
GPCR Biased Signaling in CancerAriella C Avigad, Melody Zhou, Chengyu Sun, et al.
Diseases of the Colon and Rectum|March 20, 2012
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasisPatrick L Wagner, Douglas Jones, Anna Aronova, et al.
Cancers|February 13, 2025
Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of SurvivalChelsea Knotts, Hyun Park, Christopher Sherry, et al.
Clinical and Translational Medicine|March 23, 2026
Liquid biopsy biomarkers for early detection of gastrointestinal cancers: Current landscape and emerging technologiesMuhammad Anees, Christopher Sherry, Hyun Y Park, et al.
Carcinogenesis|May 13, 2022
CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat modelAshten N Omstead, Michael Paskewicz, Anastasia Gorbunova, et al.
Pageof 6